Users Online Now: 2,046 (Who's On?) | Visitors Today: 1,364,539 | |
Pageviews Today: 1,869,675 | Threads Today: 475 | Posts Today: 8,043 |
02:48 PM |
Page 1 Previous Page Next Page | |
Cure for cancer? Israeli scientists claim to be on brink of development | |
Alluvial Offer Upgrade User ID: 76867331 United States 01/29/2019 02:43 PM Report Abusive Post Report Copyright Violation | [link to www.foxnews.com (secure)] [link to www.aol.com (secure)] [link to www.jpost.com (secure)] A small team of Israeli scientists think they might have found the first complete cure for cancer. “We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, of a new treatment being developed by his company, Accelerated Evolution Biotechnologies Ltd. (AEBi), which was founded in 2000 in the ITEK incubator in the Weizmann Science Park. AEBi developed the SoAP platform, which provides functional leads to very difficult targets. “Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor said. “Our solution will be both generic and personal.” In contrast, MuTaTo is using a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically. By using at least three targeting peptides on the same structure with a strong toxin, Morad said, “we made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.” “The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used,” Morad continued. “Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.” However, unlike in the case of AIDS, where patients must take the cocktail throughout their lives, in the case of MuTaTo, the cells would be killed, and the patient could likely stop treatment after only a few weeks. |
Page 1 Previous Page Next Page |